Bone tissue harbors unique and essential physiological processes, such as hematopoiesis, bone growth, and bone remodeling. To enable visualization of these processes at the cellular level in an intact environment, we developed "Bone CLARITY," a bone tissue clearing method. We used Bone CLARITY and a custom-built light-sheet fluorescence microscope to detect the endogenous fluorescence of Sox9-tdTomato + osteoprogenitor cells in the tibia, femur, and vertebral column of adult transgenic mice. To obtain a complete distribution map of these osteoprogenitor cells, we developed a computational pipeline that semiautomatically detects individual Sox9-tdTomato + cells in their native three-dimensional environment. Our computational method counted all labeled osteoprogenitor cells without relying on sampling techniques and displayed increased precision when compared with traditional stereology techniques for estimating the total number of these rare cells. We demonstrate the value of the clearing-imaging pipeline by quantifying changes in the population of Sox9-tdTomato-labeled osteoprogenitor cells after sclerostin antibody treatment. Bone tissue clearing is able to provide fast and comprehensive visualization of biological processes in intact bone tissue.
INTRODUCTION
The mammalian skeletal system consists of numerous bones of varying shapes and sizes that provide support to the body and protect internal organs from external physical stress (1, 2) . Different bone types harbor specialized physiological processes that are key for proper development and survival of the organism, such as replenishment of hematopoietic cells, growth, and remodeling of the bone during healthy and diseased states (3) (4) (5) (6) . Traditionally, these processes have been investigated through methods that provide zero-dimensional (0D) or 2D information, such as fluorescence-activated cell sorting or analysis of histological sections. Quantitative 3D data of geometric features, such as volume and number of cells, can be obtained from histological sections with unbiased stereological methods. Although statistically robust, these methods are labor-intensive and provide no visualization of the 3D structures. The need for methods that provide 3D information to study the bone has long been recognized. Although methods, such as serial sectioning and milling, are valuable tools for understanding the structure of bone at the tissue level, these are destructive techniques that do not provide information at the cellular level and cannot be easily combined with other methods, such as immunohistochemistry, to characterize cellular processes (7, 8) .
CLARITY (Clear Lipid-exchanged Acrylamide-hybridized Rigid Imaging/Immunostaining/In situ hybridization-compatible Tissue hYdrogel) was originally developed for soft tissues, such as the brain (9) ; recently, there has been a surge in optical clearing methods for a variety of applications (for example, profiling of tumor biopsies and brain tissue) (9) (10) (11) (12) (13) (14) (15) . Bone is a more complex histological sample, owing to its hard (mineral) and soft (bone marrow) tissue, and accordingly, osseous tissue has remained a challenge, despite some promising developments reviewed in (14, 16) . One method for investigating intact bones and their 3D microenvironments at submicrometer resolution is to render the tissue optically transparent. Bone transparency can be accomplished by coupling refractive index (RI) matching reagents with removal of minerals and lipids that scatter light. Most bone clearing literature is based on solvent clearing methods (17) (18) (19) (20) . These methods focus on RI matching and solvation of some lipids but do not remove minerals (14, 16) . In general, these solvent-based clearing methods have achieved an imaging depth of about 200 mm using two-photon microscopy (18) . Murray's clearing method was recently modified to clear bisected long bones and achieved an imaging depth of about 600 mm with confocal microscopy (21) . Despite these advances, manipulation and subsampling of the bone is required for deep imaging, thus disrupting the intact bone architecture. A key limitation of Murray's clearing method and its variants is that they quench endogenous fluorescence, minimizing their application with transgenic fluorescent reporter lines, which are used to highlight key cell populations within the bone and marrow. Consequently, there is a need for a clearing method that maintains the intact bone structure, preserves endogenous fluorescence, and allows deeper imaging within intact bone.
In our previous work (15), we noticed that decalcification (deCAL) of bones by EDTA could, in principle, expand CLARITY applications to osseous tissues, but we only achieved modest optical access (200 to 300 mm). Here, we introduce Bone CLARITY, a specialized protocol that incorporates continuous convective flow during the clearing process, amino alcohol to minimize tissue autofluorescence (22, 23) , and an imaging procedure that minimizes RI variations in light-sheet microscopy. These improvements allowed us to achieve whole-bone clearing with an imaging depth of up to about 1.5 mm while maintaining native tdTomato fluorescence and a signal-to-noise ratio (SNR) that permitted detection and 3D placement of single cells. We present a comprehensive platform based on whole-bone clearing, light-sheet imaging with a custom-built microscope, and dedicated computational methods for counting fluorescently labeled cells. We use this trio of methods to visualize and quantify the total number of osteoprogenitors contained within a volume of mouse bone and map their 3D spatial distribution in response to a sclerostin antibody (Scl-Ab), a boneforming agent.
RESULTS

Bone CLARITY renders intact bones transparent while preserving endogenous fluorescence
We developed and applied a bone clearing method to render the tibia, femur, and vertebral column of mice transparent for light microscopy investigation (Fig. 1A) . The key steps of the sample preparation, including tissue clearing and autofluorescence removal, are outlined in Fig. 1B and fig. S1 . The bone is decalcified to increase light and molecular penetration through the tissue while leaving a framework of bone matrix with similar structural characteristics to dense fibrous connective tissue. Bone CLARITY uses an acrylamide hydrogel to support the tissue structure and minimize protein loss before the delipidation step. The detergent SDS is used to remove lipids to minimize their light-scattering effects. We observed high autofluorescence in the bone marrow, one of the primary sites of heme synthesis. Because heme is strongly autofluorescent, in the final step of the process, we used the amino alcohol N,N,N′,N′-tetrakis(2-hydroxypropyl) ethylenediamine (22, 23) to remove heme, which minimized marrow autofluorescence by about threefold ( fig. S2 ). All of the above clearing stages were conducted on a temperature-controlled stir plate that provided continuous convective flow ( fig. S3 ; auxiliary design file). This accelerates and improves the clearing process for entire organs compared with passive clearing (15) . Notably, the samples did not change size during the clearing process ( fig. S4 ).
The imaging of intact bone tissue using a point-scanning method (such as a confocal microscope) poses an operational challenge because acquisition times are prolonged, with concomitant photobleaching (24) (25) (26) . To address this, we built a custom light-sheet fluorescence microscope (LSFM) with confocal slit detection ( fig. S5) (15, 27) . To modify the LSFM to image bones, we added an additional light-sheet path to illuminate the bones from two opposite directions. This additional light path improved optical access to areas containing a high percentage of cancellous bone, which typically scatter light more extensively and consequently lower the SNR. Given a particular depth scan, the sample is illuminated by only one of the two light-sheet paths, whichever provides the better contrast. We use only one illumination path per depth scan because there is always one illumination direction that scatters less light and thus provides superior image quality. To minimize RI mismatch between the objective lens and the bones, we directly immersed the samples in the immersion chamber without the use of a quartz cuvette to hold the sample. If RI variations still persist, the position of the detection objective is changed for each tile and specific depth along the Z-scan, to mitigate any resulting out-offocus aberrations. The LSFM captures images at a frame rate of 22 frames per second (16-bit depth) and produces 0.176 gigabytes (GB) of imaging data per second. Large data sets are thus acquired for each imaged bone (50 to 500 GB). To manage these large data sets, we designed a computational pipeline that includes image stitching, automatic detection of individual cells, and volume-of-interest (VOI) rendering for analysis (Fig. 1C) .
To validate the protocol, we applied our clearing and imaging method to locate progenitor cells in the long bones and vertebrae of transgenic reporter mice. A Sox9CreER transgenic mouse line was used in which, upon tamoxifen injection, multipotent osteoblast and chondrocyte progenitor cells express tdTomato (1, 28) . We visualized the endogenous fluorescence of Sox9 + cells using Bone CLARITY (Fig. 1, D and E) . Quantification of the imaging depth in different regions of the tibia, femur, and vertebral body showed that we were able to image through the diaphysis of the femur (movie S1) and tibia (movie S2) and the entire vertebral body (movie S3). Furthermore, we were able to reliably detect Sox9 + cells up to about 1.5 mm deep into the bones ( fig. S6 ). Collectively, Bone CLARITY coupled with LSFM and the data processing pipeline is an effective clearing, imaging, and data processing protocol for investigating intact mouse bones.
Semiautomated computational pipeline quantifies Sox9
+ cells in mouse tibia and femur To demonstrate that biological environments can be observed and quantified with Bone CLARITY, we first counted Sox9 + cells in the tibia and femur. We found that Bone CLARITY allows for detection and quantification of individual Sox9 + cells in 3D ( Fig. 2A) , some of which appear associated with small blood vessels. Owing to the large VOI ( Fig. 2A ; gray surface), we created a semiautomated cell detection algorithm (Fig. 2B and fig. S7 ). The algorithm divides the 2D images that make up the Z-stack (or depth scan) into n small overlapping regions, and then adaptively thresholds the 2D images into binary images on the basis of the local mean and SD of fluorescence. The resulting binary 2D images are further subjected to morphological operations to eliminate noise and discontinuity within a cell. All of the 2D binary images are then combined into a 3D matrix. From the 3D matrix, only volumes that fit the properties of a Sox9 + cell are maintained, thus avoiding erroneous counting of large blood vessels or small autofluorescence artifacts. All cells outside the user-defined VOI ( Fig. 2A) are discarded. The cell candidate centroid locations are then imported to 3D visualization software for manual quality control. During the quality control stage, the annotator reviews the entire 3D volume and corrects the automatic results by marking false-negative cells and omitting false-positive cells. Therefore, at the end of the quality control stage, the cell counts are equivalent to cell counts that were performed manually. According to our experiments, a fully automatic pipeline only achieves 52% sensitivity and 36% precision on average. Note that removing false positives is a faster operation in the 3D visualization software than adding false negatives; therefore, the value of sensitivity outweighs the need for precision.
We quantified the number of fluorescently labeled Sox9 + cells in the femur and tibia of Sox9CreER mice versus two control groups: Sox9CreER mice without tamoxifen administration and wild-type mice without the transgenes (Fig. 2C) . The analyzed volume for each group was comparable ( fig. S8 ). The cell counts in the Sox9CreER group without tamoxifen administration can be attributed to leakage of the reporter line because there was no visible expression of tdTomato in the wild-type control samples (29) . Qualitatively, this expression leakage can be observed in fig. S9 , where the expression of the tdTomato signal is compared between the experimental group and the two control groups. We next quantified the cell distribution as a function of distance from the periosteal surface along the longitudinal plane (schematic in Fig. 2D ). On the basis of our analysis, most of the cells in the diaphysis reside adjacent to the endocortical surface, with mean distances from the periosteal surface of about 136.9 and 143.6 mm for the tibia and femur, respectively (Fig. 2E ). This result supports similar findings in (30) and validates Bone CLARITY as a reliable method to resolve and quantify individual cells in intact bone and marrow spaces. Note that Bone CLARITY is not limited to visualizing cell populations in transgenic animals only and that antibody staining is also feasible ( fig. S10 ). However, for maximum penetration of the antibody into the bone for secondary staining, it is recommended to bisect the bone before the clearing process.
Bone clearing can complement section-based stereology Design-based stereology is the gold standard method to quantify total cell numbers and densities in organs while preserving spatial information (31, 32) . Stereology relies on statistical sampling methods. Systematic uniform random sampling (SURS) is a frequently used sampling method that efficiently reduces the variance of the estimate compared with random sampling. SURS obtains histological sections from an organ to reduce the amount of tissue for analysis. SURS samples at regular uniform intervals with the first sample collected at a random position within the first interval (33, 34) . The number of cells in a tissue volume is a 0D geometric feature. Thus, to avoid bias due to cell size or shape, a probe based on two thin physical sections or optical planes separated by a known distance (disector) is used to accomplish quantification (35, 36) . Cells are typically counted in a known fraction of the organ, which allows for an estimation of the total number of cells in the entire organ (37) . The spatial distribution of cells can also be obtained using second-order stereological methods (38) .
Applying stereological methods to cleared organs offers notable time-saving because clearing precludes the need for labor-intensive sectioning. Using the Bone CLARITY method and our 3D counting scheme, we investigated the variability in stereology estimates as a function of the number of slices for both SURS and simple random sampling in stereology experiment simulations. Figure 3A shows one representative selection of n random uniformly spaced sections for a simulated SURS experiment in the femur, tibia, and vertebral body. Figure 3B shows the estimates for the cell count of an entire VOI based on n sampled slices, and Fig. 3C shows the coefficient of variation of simulated stereology experiments that were conducted with n slices. To estimate the coefficient of variation for each n representative slices, we conducted five simulated stereology experiments. As expected in these simulations, variance decreased rapidly with increasing number of slices for femur, tibia, and vertebra. Precision of the stereological estimate would likely be improved with proportionator sampling, a form of nonuniform sampling better suited to rare structures (39) . Nonetheless, the 3D counting method offers several advantages for quantifying rare cellular populations: the ability to detect subtle changes that might be overlooked because of sampling variance, elimination of the need for sectioning, and 3D visualization.
Scl-Ab increases the number of Sox9 + cells in the vertebral column We next applied Bone CLARITY to the vertebral column, a bone that is highly susceptible to fractures due to osteoporosis (40) and whose complex geometry is particularly difficult to probe with traditional sectioning-based methods. We cleared and imaged the vertebrae from mice and focused on the fourth lumbar vertebral body (L4), which is dense, opaque, and predominately composed of cancellous bone. Figure 4 (A and B) shows schematics of lateral and transverse cuts from a representative vertebra. Figure 4B also shows the approximate locations (dashed lines) of the digital sections (30 mm thick) that are shown in Fig. 4C . The lateral processes that extrude from the vertebral body can be seen in the horizontal edges of the 650-mm section. These processes were excluded from the cell counts, as illustrated by the representative VOI (Fig. 4D) . In addition, careful attention was given to ensure the exclusion of the intervertebral discs 
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and cartilage endplates from the VOI because they are both primarily populated by chondrocytes. These chondrocytes express Sox9 and are tdTomato + after tamoxifen administration and thus require careful exclusion for accurate cell counts of fluorescently marked osteoprogenitors. The quantification of vertebral Sox9-tdTomato cells after tamoxifen administration versus the two control groups, Sox9CreER mice without tamoxifen administration and wild-type mice, can be seen in Fig. 4E . Again, we observed that the Sox9CreER transgenic animals without tamoxifen administration display mild leakage of tdTomato expression (Fig. 4E and fig. S9 ). Overall, similar to the cell distribution results presented for the tibia and femur, the Sox9 + cells were primarily located adjacent to the endocortical surface (Fig. 4, F and G), with a mean distance of 138.8 and 137.6 mm for the Tam   −   and Tam + groups, respectively. We next tested the effects of Scl-Ab on the total number of Sox9 + cells in the vertebral column. Sclerostin is an extracellular inhibitor of the canonical Wnt signaling pathway and is highly expressed in osteocytes. Inhibition of sclerostin leads to activation of canonical Wnt signaling in the osteoblast lineage, resulting in a rapid but transient marked increase in osteoblast number and corresponding bone formation (41) . Although the early marked increase in osteoblast number is considered to be at least in part due to activation of bone lining cells (42) , the contribution of osteoprogenitors to this early increase in osteoblast number is unclear. Although a decrease in osteoprogenitors has been demonstrated to be associated with the attenuation of bone formation that occurs with long-term Scl-Ab treatment in rats, stereological methods have not detected effects on progenitor number coincident with the maximal increase in osteoblast number. To gain insight into the acute effects of Scl-Ab on osteoprogenitors, we conducted an experiment as outlined in Fig. 4H . On day 1, Sox9CreER mice were injected with Scl-Ab (100 mg/kg subcutaneously). Four days after, we provided a second dose of Scl-Ab along with tamoxifen to label Sox9 + cells with tdTomato. We euthanized the animals 5 days later and cleared the bones using Bone CLARITY. After performing blinded quantification of Sox9 + cells, we observed an increase in the total number of Sox9 + cells in the vertebral body 9 days after initial Scl-Ab treatment versus the vehicle control group (Fig. 4I) . We did not observe any significant changes to the vertebral body volume (Fig. 4J) between the experimental and control groups at this early time point. These results demonstrate that there is an increase in osteoprogenitors that are likely recruited to the bone surface to contribute to the increase in osteoblast number. The distribution of cells as a function of distance from the surface can be seen in Fig. 4K , with mean distances of about 99.9 and 137.8 mm for the vehicle and treated groups, respectively.
DISCUSSION
In the bone remodeling process, bone health is maintained through continuous cycles of bone resorption by osteoclasts and bone formation by osteoblasts. Imbalances in these physiological processes can lead to various bone diseases, such as osteoporosis, which affect millions of people in the United States alone (40, 43) . To gain better insight into potentially effective treatments for osteoporosis, it is imperative to study the physiological processes that occur in healthy and diseased bone and understand its molecular and cellular mechanisms within the 3D microenvironment. We demonstrate that the Bone CLARITY technique renders the tibias, femurs, and vertebral bodies of mice optically transparent while preserving bone morphology and an endogenous fluorescent reporter signal. In addition to matching the RI of the tissue, Bone CLARITY also removes minerals and lipids, thus enabling us to reconstruct a whole vertebral body and the entire diaphysis from the tibia and femur.
For maximum impact, clearing and imaging platforms need to be easy to use and scalable. The trio of methods presented here has a few limitations in its current rendering that could be improved in the future, such as the addition of antibody staining to the clearing workflow, reducing processing time, and overcoming the technical barriers of acquiring and analyzing big data sets. Antibody staining of an intact bone is challenging because of poor penetration by relatively large antibodies. To improve antibody penetration, we bisected and cleared half of a tibia and femur. In the bisected and cleared bones, the antibody penetrated up to 400 mm from the bone surface and showed high specificity and SNR (fig. S10 ). The use of small-molecule staining methods [for example, single-molecule hybridization chain reaction (44) ] could allow the labeling of intact bones while achieving improved staining depths. Meanwhile, the ability to retain and detect endogenous fluorescence has proven highly enabling, although the gentle clearing reagents used in Bone CLARITY do introduce a compromise in processing time (28 days). Using faster decalcification agents, such as formic acid, might shorten the current deCAL time of 14 days, although the fluorescent proteins generated by the reporter genes used in this study might lose their fluorescence under acidic conditions (24, 45) . Delipidation is also a lengthy stage in Bone CLARITY but necessary to reduce scattering from lipids not only present in the mineralized bone tissue but also highly abundant within the bone marrow. Consequently, delipidation ensures high-quality optical access deep in the bone. Although the use of customized microscopy and software might not be easy to implement in a nontechnical setting, commercial LSFM systems with a streamlined user interface and associated software are rapidly evolving to support the types of applications described here. For data processing, we found that fully automated cell detection algorithms were difficult to apply within cleared tissue. SNR variations arising from nonuniform illumination and fluorescence detection within the bone resulted in unsatisfactory precision, necessitating manual quality control. The simple automated tools that we developed are fast and adaptive and, in general, are able to save annotator time while improving precision and reducing error; however, more work is required to achieve a reliable, fully automated algorithm for cell counting. In general, data handling, visualization, and analysis would benefit from individual developers sharing their code in an open-source environment, which would allow the scientific and medical community to efficiently customize software relevant for the application at hand.
Bone CLARITY enables clearing of mouse bones while retaining the integrity of the bone marrow and endogenous fluorescence. After clearing, we achieved 3D reconstructions of a vertebral body and long bone diaphyses and attained an imaging depth of about 1.5 mm for the epiphysis of long bones. Using a computational pipeline to process large data sets and detect single cells in bone, we mapped the spatial distribution of osteoprogenitor cells. In addition, we demonstrated the advantages of 3D methods in estimating rare cell populations that are not readily amenable to sampling by traditional stereology methods. Note that combining traditional stereology methods with tissue clearing techniques can be advantageous, especially in cases where quantification of complicated structural elements cannot be done automatically. Therefore, subsampling is advantageous for manual quantification within a reasonable time frame. Last, to further demonstrate the use of our clearing method, we treated a cohort of adult reporter mice with Scl-Ab, a bone-forming agent, for 9 days. Previous stereological studies in rats treated with Scl-Ab for 8 days revealed a marked increase in total osteoblast number in the vertebrae coincident with increased bone formation but no significant effect on bone progenitor numbers (41) . After 9 days of treatment in mice, we found that the total number of osteoblast progenitor cells increased by 36% compared with the control group. This result was not surprising based on the literature (41), but it has been challenging to demonstrate using stereological methods given the rarity of osteoprogenitor cells, particularly in the vertebrae. This underscores the greater sensitivity of our clearing, imaging, and data-processing protocol for quantifying rare cell populations and using lineage tracing to mark progenitors, as opposed to immunophenotyping in tissue sections. Overall, continued developments in tissue clearing (14, 16, 46) , imaging, and data analysis can facilitate translational research that will provide insight into the efficacy and safety of new bone-modulating drugs by profiling their effects on progenitor cell populations.
Other fields might also benefit from applying the bone clearing technique, such as neuroscience. Removal of the skull damages the interface between the skull and the underlying vascular bed and neuronal tissue. Preservation of this interface would be beneficial for studying the lymphatic vessels residing within it, assessing head trauma (for example, percussive injuries), and characterizing the positioning of head-mounted brain implants in an intact environment (47, 48) .
MATERIALS AND METHODS
Study design
The objective of this study was to enable the visualization and quantification of cell population in an intact bone tissue by developing and integrating tissue clearing, fluorescence microscopy, and a computation pipeline. Experimental and control animal cohorts were chosen based on preliminary data that suggested a large effect size. All transgenic animals used in this study are as described in the Animals section. All wild-type animals used in this study were C57BL/6. To characterize the density of Sox9 + cells and distribution within the femur, tibia, and vertebral column, male transgenic animals of 6 to 7 weeks of age received a 2 mg of tamoxifen intraperitoneally on day 1 of the experiment to enable expression of a native fluorescent gene for 7 days before culling. For the study of the effects of Scl-Ab on total number of osteoprogenitor cells, a cohort of 7-week-old male transgenic animals were treated with Scl-Ab at 100 mg/kg (subcutaneously) on day 1 and again at 100 mg/kg (subcutaneously) 4 days later with tamoxifen induction at 2 mg (intraperitoneally), before culling on day 9 of the study. The Scl-Ab was provided by Amgen. During cell counting, all manual quantification is performed in a blind manner to eliminate observer bias. Animals were randomly assigned to groups for experiments. Raw data values for cell counts are reported in the Supplementary Materials.
Animals
A transgenic Sox9-CreERT2 mouse (RIKEN BioResource Center, # RBRC05522) was crossed to a Rosa26-loxP-stop-loxP-tdTomato (R26R-tomato, JAX7914) reporter mouse to generate Sox9-CreERT2-R26-tdt. Sox9-CreERT2-R26-tdt mice aged 6-to 7-week-old were used in the experiments involved in labeling Sox9 cells (n = 18). The labeling was achieved by intraperitoneal injection of 2 mg of tamoxifen, which was dissolved first in 100% ethanol then in sunflower seed oil (Sigma-Aldrich, #S5007) overnight at 60°C. Mice were genotyped by polymerase chain reaction. All mice were analyzed in mixed backgrounds. Mice were group-housed in sterile, ventilated microisolator cages on corn cob bedding in a facility accredited by the Association for Assessment and Accreditation of Laboratory Animal Care. All procedures were conducted in compliance with the Guide for the Care and Use of Laboratory Animals approved by Massachusetts General Hospital's Institutional Animal Care and Use Committee. Animals were provided ad libitum access to pelleted feed (LabDiet 5010) and water (Standard drinking water of Boston, MA; pH 7.8) via Hydropac. Animals were maintained on a 12-hour light/12-hour dark cycle in rooms at 64°to 79°F with 30 to 70% humidity under pathogen-free conditions.
Bone deCAL CLARITY protocol
The clearing process is summarized in fig. S1 . After euthanization, mice were perfused transcardially with 0.01 M phosphate-buffered saline (PBS) (Sigma-Aldrich, #P3813) followed by 4% paraformaldehyde (PFA) (VWR, #100496-496), and the femurs, tibias, and L3 to L5 vertebral columns were extracted. The bones were postfixed overnight in 4% PFA. To enhance clearing of hard-tissue, we extended the demineralization phase to 2 weeks with 10% EDTA (Lonza, # 51234) in 0.01 M PBS (pH 8). During the demineralization phase, samples were kept under constant stirring in histology cassettes (Electron Microscopy Sciences, #70077-W) at 4°C with fresh EDTA buffer exchanges daily. Next, the decalcified bones were embedded in a hydrogel matrix (A4P0), which consists of 4% acrylamide (Bio-Rad, #1610140), 0% PFA, and 0.25% thermoinitiator (Wako Chemicals, VA-044), in 0.01 M PBS overnight at 4°C. The samples were degassed through nitrogen gas exchange for 5 min and polymerized for 3 hours at 37°C. After structural reinforcement with the A4P0 hydrogel, delipidation was performed with 8% SDS in 0.01 M PBS (pH 7.4) for 4 or 5 days (vertebral body and long bones, respectively) at 37°C under constant stirring (fig. S3) . The samples were then washed for 48 hours in 0.01 M PBS with three buffer replacements. The amino alcohol N,N,N′, N′-tetrakis(2-hydroxypropyl)ethylenediamine (Sigma-Aldrich, #122262-1L) was added at 25% w/v in 0.01 M PBS (pH 9) for 2 days at 37°C under constant stirring for the purpose of decolorization of the tissue through heme group removal. Last, the bones were washed with 0.01 M PBS for 24 hours and subsequently immersed in RI matching solution (RIMS). The bones were gradually immersed in RIMS (15) with an RI of 1.47 through daily stepwise RIMS exchange with RIMS 1.38, 1.43, and finally, 1.47.
Light-sheet microscopy imaging
Before imaging, the sample was placed in the LSFM sealed immersion chamber for at least 3 hours, allowing the RIMS solution in the chamber to equilibrate with the residue RIMS in the bone sample. To minimize optical aberrations, we measured the RI of the RIMS solution, and the correction collar on the objective lens (10× CLARITY objective lens with numerical aperture of 0.6; Olympus XLPLN10XSVMP) was set accordingly. To image the entire bone, we acquired multiple tiles with 10% overlap. Typically, the femur, tibia, and vertebral body required 13 × 5, 11 × 5, and 3 × 2 tiles, respectively (vertical × horizontal). In a calibration stage that took place before the scan, the following parameters were defined for each tile: (i) light-sheet illumination direction; the LSFM has two light sheets that illuminate the sample from opposite directions. Selecting the preferable illumination direction markedly reduced scattering. (ii) The start and end point of the Z-stack; this step was carried out to minimize the number of acquired images in an already big data set (50 to 500 GB). (iii) The focus points of the detection objective along the scan were defined to mitigate RI variations along the scan that created out-of-focus aberrations. Once the calibration stage was completed, the bone was imaged with a frame rate of 22 frames per second and bit depth of 16 bits. The acquired data set size depends on the sampled voxel size. For a voxel size of 0.585 × 0.585 × 2 mm 3 , the tibia and femur produced~250 GB of data per color channel, whereas the vertebral body produced~30 GB of data per color. Generally, the data sets are down-sampled after acquisition for processing; the typical voxel sizes are 1.17 × 1.17 × 2 mm 3 and 2.34 × 2.34 × 2 mm 3 for the vertebral column and long bones, respectively.
All experimental and control groups were imaged with the same laser power. For images that were acquired deep in the bone and when the SNR changed within the distance from the bone boundary, the contrast and gamma were adjusted in the displayed images. The gamma adjustment was performed to visualize cells that exhibit both low and high intensity within the same field of view. Images from the vertebra (Sox9 + and Tam + group) are representative of 13 vertebrae from 13 mice. Images from the tibia and femur (Sox9 + and Tam + group) are representative of five tibias and five femurs from five mice.
Statistical analysis
All statistical analyses were performed using GraphPad Prism version 7.01. For Figs. 2C and 4 (E, I, and J), mean values for each group were compared using an unpaired t test. In all graphs, data points per individual animal trial with the mean value and SEM are shown.
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